Literature DB >> 24424627

Time evaluation of image-guided radiotherapy in patients with spinal bone metastases. A single-center study.

H Rief1, D Habermehl, K Schubert, J Debus, S E Combs.   

Abstract

PURPOSE: Time is an important factor during immobilization for radiotherapy (RT) of painful spinal bone metastases. The different RT techniques currently in use have differing impacts on medical staff requirements, treatment planning and radiation delivery. This prospective analysis aimed to evaluate time management during RT of patients with spine metastases, focusing particularly on the impact of image-guided RT (IGRT).
MATERIALS AND METHODS: Between 21 March 2013 and 17 June 2013, we prospectively documented the time associated with the core work procedures involving the patient during the first day of RT at three different linear accelerators (LINACs). The study included 30 patients; 10 in each of three groups. Groups 1 and 2 were treated with a single photon field in the posterior-anterior direction; group 3 received a three-dimensional conformal treatment plan.
RESULTS: The median overall durations of one treatment session were 24 and 25.5 min for the conventional RT groups and 15 min for IGRT group. The longest single procedure was patient immobilization in group 1 (median 9.5 min), whereas this was image registration and matching in groups 2 and 3 (median duration 9.5 and 5 min, respectively). Duration of irradiation (beam-on time) was similar for all groups at 4 or 5 min. The shortest immobilization procedure was observed in group 3 with a median of 3 min, compared to 4 min in group 2 and 9.5 min in group 1.
CONCLUSION: With this analysis, we have shown for the first time that addition of modern IGRT does not extend the overall treatment time for patients with painful bone metastases and can be applied as part of clinical routine in a palliative setting. The choice of treatment technique should be based upon the patient's performance status, as well as the size of the target volume and location of the metastasis.

Entities:  

Mesh:

Year:  2014        PMID: 24424627     DOI: 10.1007/s00066-013-0494-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  10 in total

1.  [Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery : QUIRO-DEGRO Trial].

Authors:  A Zabel-du Bois; S Milker-Zabel; M Henzel; W Popp; J Debus; H Sack; R Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2012-08-01       Impact factor: 3.621

2.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial.

Authors:  E Blank; N Willich; R Fietkau; W Popp; J Schaller-Steiner; H Sack; F Wenz
Journal:  Strahlenther Onkol       Date:  2012-01-14       Impact factor: 3.621

3.  Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14.

Authors:  David D Howell; Jennifer L James; William F Hartsell; Mohan Suntharalingam; Mitchell Machtay; John H Suh; William F Demas; Howard M Sandler; Lisa A Kachnic; Lawrence B Berk
Journal:  Cancer       Date:  2012-11-16       Impact factor: 6.860

4.  Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment. The DEGRO-QUIRO trial.

Authors:  R Fietkau; W Budach; N Zamboglou; H-J Thiel; H Sack; W Popp
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

5.  Patterns of care and course of symptoms in palliative radiotherapy: a multicenter pilot study analysis.

Authors:  Birgitt van Oorschot; Michael Schuler; Anke Simon; Ursula Schleicher; Hans Geinitz
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

6.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.

Authors:  Wilfried Budach; Edwin Bölke; Rainer Fietkau; Andre Buchali; Thomas G Wendt; Wolfgang Popp; Christiane Matuschek; Horst Sack
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

7.  Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment.

Authors:  Kinsey Lam; Edward Chow; Liying Zhang; Erin Wong; Gillian Bedard; Alysa Fairchild; Vassilios Vassiliou; Mohamed Alm El-Din; Reynaldo Jesus-Garcia; Aswin Kumar; Fabien Forges; Ling-Ming Tseng; Ming-Feng Hou; Wei-Chu Chie; Andrew Bottomley
Journal:  Support Care Cancer       Date:  2013-06-19       Impact factor: 3.603

8.  Factors influencing health related quality of life in cancer patients with bone metastases.

Authors:  Erin Wong; Edward Chow; Liying Zhang; Gillian Bedard; Kinsey Lam; Alysa Fairchild; Vassilios Vassiliou; Mohamed A Alm El-Din; Reynaldo Jesus-Garcia; Aswin Kumar; Fabien Forges; Ling-Ming Tseng; Ming-Feng Hou; Wei-Chu Chie; Andrew Bottomley
Journal:  J Palliat Med       Date:  2013-07-02       Impact factor: 2.947

9.  Defining the role of palliative radiotherapy in bone metastasis from primary liver cancer: an analysis of survival and treatment efficacy.

Authors:  Daniel Habermehl; Kristina Haase; Stefan Rieken; Jürgen Debus; Stephanie E Combs
Journal:  Tumori       Date:  2011 Sep-Oct

10.  Continuous controversy about radiation oncologists' choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?

Authors:  Carsten Nieder; Adam Pawinski; Astrid Dalhaug
Journal:  Radiat Oncol       Date:  2013-04-10       Impact factor: 3.481

  10 in total
  3 in total

1.  Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial) : First results of a randomized controlled trial.

Authors:  Tanja Sprave; Vivek Verma; Robert Förster; Ingmar Schlampp; Thomas Bruckner; Tilman Bostel; Stefan Ezechiel Welte; Eric Tonndorf-Martini; Rami El Shafie; Nils Henrik Nicolay; Jürgen Debus; Harald Rief
Journal:  Strahlenther Onkol       Date:  2018-07-05       Impact factor: 3.621

2.  Intensity-modulated radiotherapy versus proton radiotherapy versus carbon ion radiotherapy for spinal bone metastases: a treatment planning study.

Authors:  Harald Rief; Naved Chaudhri; Eric Tonndorf-Martini; Thomas Bruckner; Stefan Rieken; Tilman Bostel; Robert Förster; Ingmar Schlampp; Jürgen Debus; Florian Sterzing
Journal:  J Appl Clin Med Phys       Date:  2015-11-08       Impact factor: 2.102

3.  Does kV Image Guidance for Bone Metastases Improve Pain Control?

Authors:  Ahmet S Tunceroglu; Bin Gui; Shou-En Lu; Julian Sison; Rahul Parikh; Sharad Goyal; Bruce G Haffty; Sung Kim; Salma K Jabbour
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.